Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2013, Article ID 818259, 4 pages
http://dx.doi.org/10.1155/2013/818259
Case Report

Syndrome of Inappropriate Antidiuretic Hormone Secretion and Ibuprofen, a Rare Association to Be Considered: Role of Tolvaptan

1Clinic of Internal Medicine 1, Department of Internal Medicine, University of Genoa School of Medicine, Viale Benedetto XV, 6, 16132 Genoa, Italy
2Division of Endocrinology, Department of Endocrinological and Metabolic Sciences, University of Genoa School of Medicine, Genoa, Italy

Received 13 March 2013; Accepted 15 May 2013

Academic Editors: I. Broom, M. Demura, H. Kang, and T. Nagase

Copyright © 2013 Nathan Artom et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Hannon and C. J. Thompson, “The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences,” European Journal of Endocrinology, vol. 162, no. 1, pp. S5–S12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Peri, N. Pirozzi, G. Parenti, F. Festuccia, and P. Menè, “Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH),” Journal of Endocrinological Investigation, vol. 33, no. 9, pp. 671–682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. W. Schrier, P. Gross, M. Gheorghiade et al., “Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia,” The New England Journal of Medicine, vol. 355, no. 20, pp. 2099–2112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Decaux, A. Soupart, and G. Vassart, “Non-peptide arginine-vasopressin antagonists: the vaptans,” The Lancet, vol. 371, no. 9624, pp. 1624–1632, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. E. J. Hoorn, P.-M. Bouloux, and V. Burst, “Perspectives on the management of hyponatraemia secondary to SIADH across Europe,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 26, Supplement 1, pp. S27–S32, 2012. View at Publisher · View at Google Scholar
  6. A. Peri and C. Combe, “Considerations regarding the management of hyponatraemia secondary to SIADH,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 26, Supplement 1, pp. S16–S26, 2012. View at Publisher · View at Google Scholar
  7. G. Liamis, H. Milionis, and M. Elisaf, “A review of drug-induced hyponatremia,” American Journal of Kidney Diseases, vol. 52, no. 1, pp. 144–153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. G. A. FitzGerald and C. Patrono, “The coxibs, selective inhibitors of cyclooxygenase-2,” The New England Journal of Medicine, vol. 345, no. 6, pp. 433–442, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Ducobu and P. Dupont, “Inhibition of prostaglandins in the syndrome of inappropriate antidiuretic hormone secretion (SIADH),” Presse Medicale, vol. 12, no. 20, pp. 1279–1282, 1983. View at Google Scholar · View at Scopus
  10. J. G. Verbalis, S. Adler, R. W. Schrier, T. Berl, Q. Zhao, and F. S. Czerwiec, “Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion,” European Journal of Endocrinology, vol. 164, no. 5, pp. 725–732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Rajendran, A. Grossman, and P. Kar, “Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice,” Endocrine Journal, vol. 59, no. 10, pp. 903–909, 2012. View at Publisher · View at Google Scholar
  12. M. N. Bulloch and N. A. Pinner, “Tolvaptan: a vasopressin antagonist for the management of euvolemic and hypervolemic hyponatremia,” Expert Review of Clinical Pharmacology, vol. 3, no. 5, pp. 601–612, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. R. Temple, D. J. George, A. K. Done, and J. A. Thompson, “Salicylate poisoning complicated by fluid retention,” Clinical Toxicology, vol. 9, no. 1, pp. 61–68, 1976. View at Google Scholar · View at Scopus
  14. M. Blum and A. Aviram, “Ibuprofen induced hyponatremia,” Rheumatology and Rehabilitation, vol. 19, no. 4, pp. 258–259, 1980. View at Google Scholar · View at Scopus
  15. A. M. Dunn, B. M. Buckley, J. S. Axford, and H. Berry, “Non-steroidal anti-inflammatory drugs and the kidney,” British Medical Journal, vol. 293, no. 6540, pp. 202–203, 1986. View at Google Scholar · View at Scopus
  16. I. Petersson, G. Nilsson, B. G. Hansson, and T. Hedner, “Water intoxication associated with non-steroidal anti-inflammatory drug therapy,” Acta Medica Scandinavica, vol. 221, no. 2, pp. 221–223, 1987. View at Google Scholar · View at Scopus
  17. N. T. Cheung, S. Coley, T. Sheeran, and R. D. Situnayake, “Syndrome of inappropriate secretion of antidiuretic hormone induced by diclofenac,” British Medical Journal, vol. 306, no. 6871, p. 186, 1992. View at Google Scholar · View at Scopus
  18. R. M. Rault, “Case report: hyponatremia associated with nonsteroidal antiinflammatory drugs,” American Journal of the Medical Sciences, vol. 305, no. 5, pp. 318–320, 1993. View at Google Scholar · View at Scopus
  19. T. Shimada, K. Higashi, K. Kimura, T. Shido, and K. Tomita, “Syndrome of inappropriate antidiuresis seen twice in eight years,” Endocrine Journal, vol. 42, no. 2, pp. 163–169, 1995. View at Google Scholar · View at Scopus
  20. I. Meyer, D. Frank, and U. Janssens, “A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH)-treatment with tolvaptan,” Dtsch Med Wochenschr, vol. 137, no. 21, pp. 1096–1099, 2012. View at Publisher · View at Google Scholar
  21. J. R. Vane, Y. S. Bakhle, and R. M. Botting, “Cyclooxygenases 1 and 2,” Annual Review of Pharmacology and Toxicology, vol. 38, pp. 97–120, 1998. View at Google Scholar · View at Scopus
  22. J. F. Dasta, J. R. Chiong, and R. Christian, “Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials,” Hospital Practice, vol. 40, no. 1, pp. 7–14, 2012. View at Google Scholar